2015
Integrated genomic characterization of IDH1-mutant glioma malignant progression
Bai H, Harmancı AS, Erson-Omay EZ, Li J, Coşkun S, Simon M, Krischek B, Özduman K, Omay SB, Sorensen EA, Turcan Ş, Bakırcığlu M, Carrión-Grant G, Murray PB, Clark VE, Ercan-Sencicek AG, Knight J, Sencar L, Altınok S, Kaulen LD, Gülez B, Timmer M, Schramm J, Mishra-Gorur K, Henegariu O, Moliterno J, Louvi A, Chan TA, Tannheimer SL, Pamir MN, Vortmeyer AO, Bilguvar K, Yasuno K, Günel M. Integrated genomic characterization of IDH1-mutant glioma malignant progression. Nature Genetics 2015, 48: 59-66. PMID: 26618343, PMCID: PMC4829945, DOI: 10.1038/ng.3457.Peer-Reviewed Original ResearchConceptsDevelopmental transcription factorsActivation of MYCMalignant progressionGenomic approachesPI3K pathwayGlioma malignant progressionEpigenetic silencingIDH1 mutant gliomasTranscription factorsIntegrated genomic characterizationGenomic characterizationRTK-RASOncogenic pathwaysK pathwayClonal expansionPathwaySilencingMYCProgression
2012
Notch and disease: A growing field
Louvi A, Artavanis-Tsakonas S. Notch and disease: A growing field. Seminars In Cell And Developmental Biology 2012, 23: 473-480. PMID: 22373641, PMCID: PMC4369912, DOI: 10.1016/j.semcdb.2012.02.005.Peer-Reviewed Original ResearchConceptsCellular fate choicesAdult stem cellsInvolvement of NotchFate choiceNotch receptorsHuman diseasesNormal developmentPleiotropic fashionStem cellsRational therapeutic avenueBiologyTherapeutic avenuesBroad actionPathwayProfound involvementComplex controlExperimental systemNotchRelated pathologiesCellsReceptorsPathobiology